ML-9 |
Katalog-Nr.GC49440 |
ML-9 ist ein selektiver und potenter Inhibitor der Akt-Kinase, hemmt die AktivitÄt der Myosin-Leichtketten-Kinase (MLCK) und des stromalen InteraktionsmolekÜls 1 (STIM1). ML-9 hemmt die MLCK-, PKA- und PKC-AktivitÄt mit Ki-Werten von 4, 32 bzw. 54μM. ML-9 induziert Autophagie, indem es die Bildung von Autophagosomen stimuliert und deren Abbau hemmt.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 105637-50-1
Sample solution is provided at 25 µL, 10mM.
ML-
1.Ito, S., Kume, H., Honjo, H., et al.ML-9, a myosin light chain kinase inhibitor, reduces intracellular Ca2+ concentration in guinea pig trachealisEuropean Journal of Pharmacology486325-333(2004) 2.Smith, U., Carvalho, E., Mosialou, E., et al.PKB inhibition prevents the stimulatory effect of insulin on glucose transport and protein translocation but not the antilipolytic effect in rat adipocytesBiochemical and Biophysical Research Communications268315-320(2000)
Average Rating: 5
(Based on Reviews and 16 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *